Terms: = Gastric cancer AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1 AND Prognosis
11 results:
1. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression.
Abe D; Akazawa Y; Yatagai N; Hayashi T; Ueyama H; Mine S; Fukunaga T; Nagahara A; Yao T; Saito T
Virchows Arch; 2023 Sep; 483(3):405-414. PubMed ID: 37581693
[TBL] [Abstract] [Full Text] [Related]
3. Targeting gpc3
Li D; Wang Y; Shi C; Fu S; Sun YF; Li C
Ann Med; 2023 Dec; 55(1):2189295. PubMed ID: 37036308
[TBL] [Abstract] [Full Text] [Related]
4. Both the serum AFP test and AFP/gpc3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma.
Wang B; Xie Y; Zheng L; Zheng X; Gao J; Liu X; Yuan Y; Li Z; Lu N; Xue L
BMC Gastroenterol; 2021 Oct; 21(1):408. PubMed ID: 34706681
[TBL] [Abstract] [Full Text] [Related]
5. Identifying Novel Cell Glycolysis-Related Gene Signature Predictive of Overall Survival in gastric cancer.
Zhao X; Zou J; Wang Z; Li G; Lei Y
Biomed Res Int; 2021; 2021():9656947. PubMed ID: 33791386
[TBL] [Abstract] [Full Text] [Related]
6. Integrated clinicopathological and immunohistochemical analysis of gastric adenocarcinoma with hepatoid differentiation: an exploration of histogenesis, molecular characteristics, and prognostic markers.
He F; Fu Y; Sun Q; Geng P; Zheng Z; Pu X; Shi J; Fan X
Hum Pathol; 2021 Sep; 115():37-46. PubMed ID: 33636206
[TBL] [Abstract] [Full Text] [Related]
7. Development and Validation of a Scoring System Based on 9 Glycolysis-Related Genes for prognosis Prediction in gastric cancer.
Luo T; Du Y; Duan J; Liang C; Chen G; Jiang K; Chen Y; Chen Y
Technol Cancer Res Treat; 2020; 19():1533033820971670. PubMed ID: 33161837
[TBL] [Abstract] [Full Text] [Related]
8. [gastric adenocarcinoma with enteroblastic differentiation and elevated serum alpha fetoprotein].
Li QZ; Zhao HB; Ban N; Wang Q; Zhang JJ; Ding SN; Li HH; Zhou ZH
Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):886-890. PubMed ID: 32892552
[No Abstract] [Full Text] [Related]
9. gastric cancer With Primitive Enterocyte Phenotype: An Aggressive Subgroup of Intestinal-type Adenocarcinoma.
Yamazawa S; Ushiku T; Shinozaki-Ushiku A; Hayashi A; Iwasaki A; Abe H; Tagashira A; Yamashita H; Seto Y; Aburatani H; Fukayama M
Am J Surg Pathol; 2017 Jul; 41(7):989-997. PubMed ID: 28505005
[TBL] [Abstract] [Full Text] [Related]
10. Establishment and biological characterization of a novel cell line derived from hepatoid adenocarcinoma originated at the ampulla of Vater.
Takahashi N; Aoyama F; Hiyoshi M; Kataoka H; Sawaguchi A
Int J Oncol; 2014 Apr; 44(4):1139-45. PubMed ID: 24481592
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathological features of long-term survivors of scirrhous gastric cancer.
Takahashi I; Matsusaka T; Onohara T; Nishizaki T; Ishikawa T; Tashiro H; Wakasugi K; Kume K; Maehara Y; Sugimachi K
Hepatogastroenterology; 2000; 47(35):1485-8. PubMed ID: 11100383
[TBL] [Abstract] [Full Text] [Related]
